Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
MULTICENTER STUDY
Matheus Simonato, Brian Whisenant, Henrique Barbosa Ribeiro, John G Webb, Ran Kornowski, Mayra Guerrero, Harindra Wijeysundera, Lars Søndergaard, Ole De Backer, Pedro Villablanca, Charanjit Rihal, Mackram Eleid, Jörg Kempfert, Axel Unbehaun, Magdalena Erlebach, Filip Casselman, Matti Adam, Matteo Montorfano, Marco Ancona, Francesco Saia, Timm Ubben, Felix Meincke, Massimo Napodano, Pablo Codner, Joachim Schofer, Marc Pelletier, Anson Cheung, Mony Shuvy, José Honório Palma, Diego Felipe Gaia, Alison Duncan, David Hildick-Smith, Verena Veulemans, Jan-Malte Sinning, Yaron Arbel, Luca Testa, Arend de Weger, Helene Eltchaninoff, Thibault Hemery, Uri Landes, Didier Tchetche, Nicolas Dumonteil, Josep Rodés-Cabau, Won-Keun Kim, Konstantinos Spargias, Panagiota Kourkoveli, Ori Ben-Yehuda, Rui Campante Teles, Marco Barbanti, Claudia Fiorina, Arun Thukkani, G Burkhard Mackensen, Noah Jones, Patrizia Presbitero, Anna Sonia Petronio, Abdelhakim Allali, Didier Champagnac, Sabine Bleiziffer, Tanja Rudolph, Alessandro Iadanza, Stefano Salizzoni, Marco Agrifoglio, Luis Nombela-Franco, Nikolaos Bonaros, Malek Kass, Giuseppe Bruschi, Nicolas Amabile, Adnan Chhatriwalla, Antonio Messina, Sameer A Hirji, Martin Andreas, Robert Welsh, Wolfgang Schoels, Farrel Hellig, Stephan Windecker, Stefan Stortecky, Francesco Maisano, Gregg W Stone, Danny Dvir
BACKGROUND: Mitral valve-in-valve (ViV) and valve-in-ring (ViR) are alternatives to surgical reoperation in patients with recurrent mitral valve failure after previous surgical valve repair or replacement. Our aim was to perform a large-scale analysis examining midterm outcomes after mitral ViV and ViR. METHODS: Patients undergoing mitral ViV and ViR were enrolled in the Valve-in-Valve International Data Registry. Cases were performed between March 2006 and March 2020...
January 12, 2021: Circulation
#2
REVIEW
Katie Linden, Conor McQuillan, Paul Brennan, Ian B A Menown
INTRODUCTION: Many important clinical trials in cardiology were published or presented at major international meetings throughout 2018. This paper aims to offer a concise overview of these significant advances and to put them into clinical context. METHODS: Trials presented at the major international cardiology meetings during 2018 were reviewed including The American College of Cardiology, EuroPCR, The European Society of Cardiology, PCR London Valves, Transcatheter Cardiovascular Therapeutics, and the American Heart Association...
July 2019: Advances in Therapy
#3
JOURNAL ARTICLE
Rick A Nishimura, Patrick T O'Gara, Joseph E Bavaria, Ralph G Brindis, John D Carroll, Clifford J Kavinsky, Brian R Lindman, Jane A Linderbaum, Stephen H Little, Michael J Mack, Laura Mauri, William R Miranda, David M Shahian, Thoralf M Sundt
No abstract text is available yet for this article.
May 28, 2019: Journal of the American College of Cardiology
#4
REVIEW
Rick A Nishimura, Patrick T O'Gara, Joseph E Bavaria, Ralph G Brindis, John D Carroll, Clifford J Kavinsky, Brian R Lindman, Jane A Linderbaum, Stephen H Little, Michael J Mack, Laura Mauri, William R Miranda, David M Shahian, Thoralf M Sundt
No abstract text is available yet for this article.
July 1, 2019: Catheterization and Cardiovascular Interventions
#5
REVIEW
Miguel Sousa Uva
The median age of patients treated by transcatheter aortic valve implantation (TAVI) is falling across Europe, and low-risk patients with severe aortic stenosis (AS) represent 80% of patients with severe AS undergoing surgical aortic valve replacement (SAVR). There are few data for TAVI in low-risk patients, but there are four ongoing randomised trials of SAVR versus TAVI. The key issues relate to pacemaker implantation rates and the associated potential longer term deleterious effects, and the need to minimise vascular complications and paravalvular leak...
March 2019: Heart
#6
REVIEW
Sergio Perez, Torin P Thielhelm, Mauricio G Cohen
Concomitant coronary artery disease (CAD) and aortic stenosis occur in approximately 60-75% of patients referred for surgical or transcatheter aortic valve replacement (TAVR). Current guidelines support simultaneous surgical aortic valve replacement and bypass surgery with a class IIa recommendation, based on observational, non-randomized data. With the inception of TAVR, this strategy has been challenged, as observational studies have not shown significant outcome differences in patients with and without CAD treated with TAVR...
November 2018: Journal of Thoracic Disease
#7
JOURNAL ARTICLE
Jubo Jiang, Xianbao Liu, Yuxin He, Qiyuan Xu, Qifeng Zhu, Sanjay Jaiswal, Lihan Wang, Po Hu, Feng Gao, Yinghao Sun, Chunhui Liu, Xiaoping Lin, Jie Liang, Kaida Ren, Jian Apos An Wang
BACKGROUND: Transcatheter aortic valve replacement (TAVR) is a recent and an effective treatment option for high- or extreme-surgical-risk patients with symptomatic severe aortic stenosis. However, pure severe native aortic valve regurgitation (NAVR) without aortic stenosis remains a contraindication to TAVR. The aim of our systemic review analysis was to evaluate TAVR in patients with pure NAVR. METHODS: We searched the published articles in the PubMed and Web of Science databases (2002-2017) using the Boolean operators for studies of NAVR patients undergoing TAVR...
2018: Cardiology
#8
JOURNAL ARTICLE
Brett Oestreich, Sergey Gurevich, Selcuk Adabag, Rosemary Kelly, Gregory Helmer, Ganesh Raveendran, Demetris Yannopoulos, Timinder Biring, Santiago Garcia
BACKGROUND: Tissue edema and inflammation, which occur at the device landing zone during valve deployment, may contribute to the pathophysiology of conduction abnormalities after transcatheter aortic valve replacement (TAVR). We hypothesized that exposure to glucocorticoids prior to TAVR will reduce the incidence of conduction abnormalities requiring PPM implantation after TAVR. METHODS: We included 167 consecutive patients treated with TAVR at the Minneapolis VA Medical Center and University of Minnesota...
April 2019: Cardiovascular Revascularization Medicine: Including Molecular Interventions
#9
JOURNAL ARTICLE
Joseph E Bavaria, Carl L Tommaso, Ralph G Brindis, John D Carroll, G Michael Deeb, Ted E Feldman, Thomas G Gleason, Eric M Horlick, Clifford J Kavinsky, Dharam J Kumbhani, D Craig Miller, A Allen Seals, David M Shahian, Richard J Shemin, Thoralf M Sundt, Vinod H Thourani
No abstract text is available yet for this article.
January 29, 2019: Journal of the American College of Cardiology
#10
JOURNAL ARTICLE
Rajkumar Doshi
No abstract text is available yet for this article.
July 20, 2018: EuroIntervention
#11
REVIEW
Russell James Everett, Marie-Annick Clavel, Philippe Pibarot, Marc Richard Dweck
No abstract text is available yet for this article.
December 2018: Heart
#12
REVIEW
Erwan Salaun, Marie-Annick Clavel, Josep Rodés-Cabau, Philippe Pibarot
The main limitation of bioprosthetic valves is their limited durability, which exposes the patient to the risk of aortic valve reintervention. Transcatheter aortic valve implantation (TAVI) is considered a reasonable alternative to surgical aortic valve replacement (SAVR) in patients with intermediate or high surgical risk. TAVI is now rapidly expanding towards the lower risk populations. Although the results of midterm durability of the transcatheter bioprostheses are encouraging, their long-term durability remains largely unknown...
August 2018: Heart
#13
REVIEW
Rebecca T Hahn, Alina Nicoara, Samir Kapadia, Lars Svensson, Randolph Martin
Transcatheter aortic valve replacement has become an accepted alternative to surgery for patients with severe, symptomatic aortic stenosis who are inoperable or are at high surgical risk. Recent trials support the use of transcatheter aortic valve replacement also in patients at intermediate risk, and ongoing trials are assessing appropriateness in other patient groups. The authors review the key anatomic features integral to the transcatheter aortic valve replacement procedure and the echocardiographic imaging required for preprocedural, intraprocedural, and postprocedural assessment...
April 2018: Journal of the American Society of Echocardiography
#14
JOURNAL ARTICLE
Volkmar Falk, Helmut Baumgartner, Jeroen J Bax, Michele De Bonis, Christian Hamm, Per Johan Holm, Bernard Iung, Patrizio Lancellotti, Emmanuel Lansac, Daniel Rodriguez Muñoz, Raphael Rosenhek, Johan Sjögren, Pilar Tornos Mas, Alec Vahanian, Thomas Walther, Olaf Wendler, Stephan Windecker, Jose Luis Zamorano
No abstract text is available yet for this article.
October 1, 2017: European Journal of Cardio-thoracic Surgery
#15
REVIEW
Catherine M Otto
No abstract text is available yet for this article.
January 2018: Heart
#16
JOURNAL ARTICLE
Oscar Millan-Iturbe, Fadi J Sawaya, Jacob Lønborg, Danny H F Chow, Gintautas Bieliauskas, Thomas Engstrøm, Lars Søndergaard, Ole De Backer
Transcatheter aortic valve replacement (TAVR) has become an established therapeutic option for patients with symptomatic, severe aortic stenosis. The optimal treatment strategy for concomitant coronary artery disease (CAD) has not been tested prospectively in a randomized clinical trial. This study aimed to describe the degree of CAD, revascularization strategies, and long-term clinical outcomes in a large-scale all-comers TAVR-population. Nine hundred and forty-four consecutive patients underwent TAVR. Obstructive CAD was reported in 224 patients (23...
October 1, 2018: Catheterization and Cardiovascular Interventions
#17
JOURNAL ARTICLE
Robert O Bonow, Alan S Brown, Linda D Gillam, Samir R Kapadia, Clifford J Kavinsky, Brian R Lindman, Michael J Mack, Vinod H Thourani
No abstract text is available yet for this article.
November 14, 2017: Journal of the American College of Cardiology
#18
JOURNAL ARTICLE
John U Doherty, Smadar Kort, Roxana Mehran, Paul Schoenhagen, Prem Soman
No abstract text is available yet for this article.
September 26, 2017: Journal of the American College of Cardiology
#19
REVIEW
Björn Redfors, Philippe Pibarot, Linda D Gillam, Daniel Burkhoff, Jeroen J Bax, Brian R Lindman, Robert O Bonow, Patrick T O'Gara, Martin B Leon, Philippe Généreux
Aortic stenosis is 1 of the most common heart valve diseases among adults. When symptoms develop, prognosis is poor, and current guidelines recommend prompt aortic valve replacement. Depending of the severity of the aortic stenosis and the presence of concomitant heart disease and medical comorbidities, stress testing represents a reasonable strategy to help better risk stratify asymptomatic patients. The present report provides a comprehensive review of the current available data on stress testing in aortic stenosis and subsequently summarizes its potential for guiding the optimal timing of aortic valve replacement...
May 16, 2017: Circulation
#20
REVIEW
Rick A Nishimura, Catherine M Otto, Robert O Bonow, Blase A Carabello, John P Erwin, Lee A Fleisher, Hani Jneid, Michael J Mack, Christopher J McLeod, Patrick T O'Gara, Vera H Rigolin, Thoralf M Sundt, Annemarie Thompson
No abstract text is available yet for this article.
June 20, 2017: Circulation
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
